Descriptor English: | Cefmenoxime | ||||||
Descriptor Spanish: |
Cefmenoxima
| ||||||
Descriptor Portuguese: | Cefmenoxima | ||||||
Descriptor French: | Cefménoxime | ||||||
Entry term(s): |
Abbott 50192 Abbott-50192 Abbott50192 Cefmax Cefmenoxime Hydrochloride Cefmenoxime Hydrochloride (2:1) Hydrochloride, Cefmenoxime SCE 1365 SCE-1365 SCE1365 |
||||||
Tree number(s): |
D02.065.589.099.249.190.190.125 D02.886.665.074.190.190.125 D03.633.100.300.249.190.190.125 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015281 | ||||||
Scope note: | A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents |
||||||
Registry Number: | KBZ4844CXN | ||||||
CAS Type 1 Name: | 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(Z)))- | ||||||
Previous Indexing: |
Cefotaxime (1982-1988) Cephalosporins (1979-1981) |
||||||
Public MeSH Note: | 89 |
||||||
History Note: | 89 |
||||||
DeCS ID: | 23575 | ||||||
Unique ID: | D015281 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1989/01/01 | ||||||
Date of Entry: | 1988/05/23 | ||||||
Revision Date: | 2016/05/28 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Cefmenoxime
- Preferred
Cefmax
- Narrower
SCE-1365
- Narrower
Abbott-50192
- Narrower
Cefmenoxime Hydrochloride
- Narrower
Concept UI |
M0023523 |
Scope note | A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. |
Preferred term | Cefmenoxime |
Concept UI |
M0023524 |
Preferred term | Cefmax |
Concept UI |
M0351047 |
Preferred term | SCE-1365 |
Entry term(s) |
SCE 1365 SCE1365 |
Concept UI |
M0351048 |
Preferred term | Abbott-50192 |
Entry term(s) |
Abbott 50192 Abbott50192 |
Concept UI |
M0023525 |
Preferred term | Cefmenoxime Hydrochloride |
Entry term(s) |
Cefmenoxime Hydrochloride (2:1) Hydrochloride, Cefmenoxime |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey